5401 篇
13911 篇
478084 篇
16320 篇
11773 篇
3942 篇
6548 篇
1254 篇
75673 篇
37947 篇
12175 篇
1667 篇
2870 篇
3423 篇
641 篇
1241 篇
1980 篇
4924 篇
3888 篇
5493 篇
全球基因组学生物标志物市场报告(2017-2021年)
Global Genomics Biomarkers Market 2017-2021
A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions.A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).In this report, Technavio covers the present scenario and growth prospects of the global genomics biomarkers market for 2016-2021 (base year: 2016; forecast end
year: 2021).
PART 01: Executive summary 6
PART 02: Scope of the report 17
Market overview 17
Top-vendor offerings 19
PART 03: Market research methodology 21
Research methodology 21
Economic indicators 21
PART 04: Introduction 22
Key market highlights 22
PART 05: Market landscape 25
Market overview 25
Market size and forecast 25
Five forces analysis 28
PART 06: Market segmentation by indication 29
PART 07: Market segmentation by end-user 33
Diagnostic and research laboratories 33
Hospitals 34
PART 08: Geographical segmentation 35
Genomics biomarkers market in Americas 36
Genomics biomarkers market in EMEA 39
Genomics biomarkers market in APAC 43
PART 09: Market drivers 47
Increasing low-cost clinical trials in developing
countries 47
Improving research network infrastructures 48
Genomics biomarker-based personalized medicine 49
PART 10: Impact of drivers 50
PART 11: Market challenges 51
Reproducibility of genomic biomarkers and tests leading
to discrepancies 51
Delay in time from lab to market 52
Reimbursement challenges for genomics biomarkersbased
tests 52
PART 12: Impact of drivers and challenges 54
PART 13: Market trends 55
Improvement in care delivery with advances in genomics
technologies 55
Expansion of new business models 57
Development of affordable genomic biomarkers as
diagnostics for tropical diseases 58
PART 14: Vendor landscape 59
PART 15: Key vendor analysis 62
Roche Diagnostics 62
Myriad Genetics 65
QIAGEN 67
Thermo Fisher Scientific 72
Bio-Rad Laboratories 74
Other prominent vendors 78
PART 16: Appendix 81
List of abbreviations 81
PART 17: Explore Technavio 82